Abstract
Antimicrobial treatment of otitis media, especially drug dosing considerations, is largely empiric, with few reported pharmacologic studies of drug distribution into the middle ear. A chinchilla animal model of serous and purulent otitis media has been used for some time to investigate mechanisms of disease pathogenesis. This model was adapted to investigate the penetration of amoxicillin, trimethoprim, and sulfamethoxazole into middle ear effusion. Purulent otitis media was produced by direct middle ear inoculation with type 7F Streptococcus pneumoniae. Serous otitis media was produced by eustachian tube obstruction using silastic sponge or Coeflex cement, but the Coeflex caused an undesirable local inflammatory response. The three antibiotics were administered to chinchillas with serous and purulent middle ear effusion. Plasma and ear fluid drug concentrations were measured by liquid chromatography and demonstrated the value of this model in assessing antibiotic penetration.
Similar content being viewed by others
REFERENCES
G. S. Giebink and D. M. Canafax. In S. C. Aronoff, W. T. Hughes, S. Kohl, N. T. Speck, and E. R. Wald (eds.), Advances in Pediatric Infectious Diseases, Year Book Medical, Chicago, Vol. 3, 1988.
G. S. Giebink, W. L. Meyerhoff, and E. I. Cantekin. In Experimental Models in Antimicrobial Chemotherapy, Vol. 1, Academic Press, London, 1986, pp. 213–36.
G. S. Giebink. Rev. Infect. Dis. 3:342–352 (1981).
G. S. Giebink. Infect. Immunol. 41:913–920 (1983).
G. S. Giebink, R. A. Heller, and E. R. Harford. Ann. Otol. Rhinol. Laryngol. 91:20–24 (1982).
T. T. K. Jung, S.-J. Hwang, D. Pool, et al. In D. J. Lim (ed.), Recent Advances in Otitis Media, B. C. Decker, Philadelphia, 1988.
M. L. Ripley-Petzoldt and G. S. Giebink. J. Infect. Dis. 157:245–255 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Canafax, D.M., Nonomura, N., Erdmann, G.R. et al. Experimental Animal Models for Studying Antimicrobial Pharmacokinetics in Otitis Media. Pharm Res 6, 279–285 (1989). https://doi.org/10.1023/A:1015938205892
Issue Date:
DOI: https://doi.org/10.1023/A:1015938205892